Epigenetic Silencing of Death Receptor 4 Mediates Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Gliomas

被引:45
作者
Elias, Agnes [1 ]
Siegelin, Markus D. [1 ]
Steinmueller, Albert [1 ]
von Deimling, Andreas [1 ,2 ]
Lass, Ulrike [2 ]
Korn, Bernhard [3 ]
Mueller, Wolf [1 ]
机构
[1] Heidelberg Univ, Inst Pathol, Dept Neuropathol, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, Clin Cooperat Unit Neuropathol G380, D-6900 Heidelberg, Germany
[3] German Canc Res Ctr, Genom & Prote Core Facil, D-6900 Heidelberg, Germany
关键词
DRUG-INDUCED APOPTOSIS; REPAIR GENE MGMT; PROMOTER METHYLATION; DOWN-REGULATION; CELLS; HYPERMETHYLATION; GLIOBLASTOMA; CASPASE-8; DR4; EXPRESSION;
D O I
10.1158/1078-0432.CCR-09-1125
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Purpose: To identify and characterize epigenetically regulated genes able to predict sensitivity or resistance to currently tested chemotherapeutic agents in glioma therapy. Experimental Design: We used methylation-sensitive BeadArray technology to identify novel epigenetically regulated genes associated with apoptosis and with potential therapeutic targets in glioma therapy. To elucidate the functional consequences of promoter methylation in the identified target death receptor 4 (DR4), we investigated tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated and anti-DR4-mediated apoptosis in glioma cell lines (U373 and A172) with loss of DR4 and one glioma cell line (LN18) with robust DR4 expression. Results: In human astrocytic tumors, we detected DR4 promoter hypermethylation in 60% (n = 5) of diffuse astrocytomas WHO grade 2, in 75% (n = 8) of anaplastic astrocytomas WHO grade 3, and in 70% of glioblastomas WHO grade 4 (n = 33). DR4 is a cell surface protein restricted to glioma cells and is targeted by TRAIL. Glioma cell lines U373 and A172 harbored heavily methylated DR4 promoters, and 5-aza-2-deoxycytidine-mediated demethylation reconstituted DR4 expression in these cell lines. Functional knockdown of DR4 by DR4-specific small interfering RNA in TRAIL-sensitive glioma cell line LN18 significantly mitigated apoptosis induced by an agonistic anti-DR4 antibody. 5-Aza-2-deoxycytidine-mediated demethylation resulted in a functional reconstitution of DR4 on the cell surface of TRAIL-resistant glioma cell line U373 and sensitized U373 to TRAIL-mediated apoptosis. Suppression of DR4 by small interfering RNA in demethylated U373 successfully reestablished the TRAIL-resistant phenotype of U373. Conclusions: DR4 promoter methylation is frequent in human astrocytic gliomas, and epigenetic silencing of DR4 mediates resistance to TRAIL/DR4-based glioma therapies. (Clin Cancer Res 2009;15(17):5457-65)
引用
收藏
页码:5457 / 5465
页数:9
相关论文
共 28 条
[1]
AGUILERA DG, 2009, J NEUROONCOL
[2]
To kill a tumor cell: the potential of proapoptotic receptor agonists [J].
Ashkenazi, Avi ;
Herbst, Roy S. .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (06) :1979-1990
[3]
Caspase 8 is absent or low in many ex vivo gliomas [J].
Ashley, DM ;
Riffkin, CD ;
Muscat, AM ;
Knight, MJ ;
Kaye, AH ;
Novak, U ;
Hawkins, CJ .
CANCER, 2005, 104 (07) :1487-1496
[4]
Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL [J].
Bae, S. I. ;
Cheriyath, V. ;
Jacobs, B. S. ;
Reu, F. J. ;
Borden, E. C. .
ONCOGENE, 2008, 27 (04) :490-498
[5]
High-throughput DNA methylation profiling using universal bead arrays [J].
Bibikova, M ;
Lin, ZW ;
Zhou, LX ;
Chudin, E ;
Garcia, EW ;
Wu, B ;
Doucet, D ;
Thomas, NJ ;
Wang, YH ;
Vollmer, E ;
Goldmann, T ;
Seifart, C ;
Jiang, W ;
Barker, DL ;
Chee, MS ;
Floros, J ;
Fan, JB .
GENOME RESEARCH, 2006, 16 (03) :383-393
[6]
CAPPER D, 2009, ACTA NEUROPATHOL
[7]
Tumor necrosis factor-related apoptosis-inducing ligand pathway and its therapeutic implications [J].
de Vries, EGE ;
Gietema, JA ;
de Jong, S .
CLINICAL CANCER RESEARCH, 2006, 12 (08) :2390-2393
[8]
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents [J].
Esteller, M ;
Garcia-Foncillas, J ;
Andion, E ;
Goodman, SN ;
Hidalgo, OF ;
Vanaclocha, V ;
Baylin, SB ;
Herman, JG .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (19) :1350-1354
[9]
Illumina universal bead arrays [J].
Fan, Jian-Bing ;
Gunderson, Kevin L. ;
Bibikova, Marina ;
Yeakley, Joanne M. ;
Chen, Jing ;
Wickham Garcia, Eliza ;
Lebruska, Lori L. ;
Laurent, Marc ;
Shen, Richard ;
Barker, David .
DNA MICROARRAYS PART A: ARRAY PLATFORMS AND WET-BENCH PROTOCOLS, 2006, 410 :57-+
[10]
Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo [J].
Fulda, S ;
Wick, W ;
Weller, M ;
Debatin, KM .
NATURE MEDICINE, 2002, 8 (08) :808-815